Iconovo And Amneal Collaborate On Symbicort Rival
Planning Development Program Following Iconovo’s Pilot Study
Iconovo has brought Amneal on board as a partner to help develop a generic version of AstraZeneca’s Symbicort respiratory brand, as the Swedish inhalation specialist prepares to make major investments in the project.
